We’re pleased to share that Evinco Therapeutics CEO and Executive Chair, Prof. Alan Trounson AO, recently joined award-winning journalist Daniel Levine on The Bio Report to discuss Evinco’s innovative approach to Alzheimer’s disease.

Hosted by Daniel Levine of Levine Media Group, The Bio Report explores the intersection of biotechnology with business, science and policy.

In conversation with Danny, Alan discusses Evinco’s multifaceted therapeutic approach, including how its immune-derived extracellular vesicles are designed to reach the brain and their potential to:

• modulate neuroinflammation
• influence the brain’s immune environment
• support the function of immune cells in the brain
• promote amyloid clearance.

The discussion provides an insight into Evinco’s NK-EV therapeutic platform and its potential to target the brain’s immune system as part of a new approach to Alzheimer’s disease.

Listen to the full episode:
Targeting the Brain’s Immune System in Alzheimer’s Disease